Education
About Us
Working with TipRanks
Follow Us
ImmunoCellular Therapeutics (IMUC)
OTHER OTC:IMUC
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -2.01M | $ -1.65M | $ -2.89M | $ -2.61M | $ -1.45M |
| EBITDA | $ -929.09K | $ -999.29K | $ -2.21M | $ -1.00 | $ 0.00 |
| Net Income | $ -1.89M | $ -1.61M | $ -2.65M | $ -2.68M | $ -1.45M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 98.67K | $ 278.26K | $ 613.24K | $ 1.49M | $ 262.98K |
| Total Assets | $ 389.67K | $ 409.42K | $ 768.80K | $ 1.67M | $ 266.70K |
| Total Debt | $ 441.88K | $ 4.74M | $ 3.47M | $ 2.82M | $ 0.00 |
| Net Debt | $ 343.21K | $ 4.46M | $ 2.85M | $ 1.33M | $ -262.98K |
| Total Liabilities | $ 1.01M | $ 6.10M | $ 4.96M | $ 3.28M | $ 137.13K |
| Stockholders' Equity | $ -617.86K | $ -5.69M | $ -4.19M | $ -1.62M | $ 129.58K |
| Cash Flow | |||||
| Free Cash Flow | $ -2.68M | $ -1.42M | $ -2.62M | $ -2.31M | $ -1.24M |
| Operating Cash Flow | $ -2.68M | $ -1.42M | $ -2.62M | $ -2.31M | $ -1.24M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 2.50M | $ 1.09M | $ 1.75M | $ 3.53M | $ 1.50M |
ImmunoCellular Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.